Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Profiteer who wrote (3097)	7/13/1998 9:01:00 AM
From: dwlima	Read Replies (1) \| Respond to of 5402

i read the entremed article in businessweek. Dr. Jonas ??? was nearing the end of his dream as his research funds were nearly depleted. on top of that, doctors at Harvard and others thought he was on the wrong path...and a quack besides that. then, he obtained a 10 year, $23M contract from Monsanto to do his research. he found two chemicals that could help keep cancer tumors in check- neither destroying them nor allowing them to grow. it works amazingly well in mice and it is though that it will have a major to profound impact on treating humans...however, no one is certain as mice's vascular systems are different. Jonas first discovered his path of research while working at Bethesda Naval Academy on Blood substitutes. He was 27 years old and made some interesting observations back in the 60s. We are doing nothing new here at SGNC. if we have found a blood substitiute that is effacacious and safe.....we are in the $. after all, there is a lot of large pharmaceuticals looking to mass produce this stuff. dwlima